FOQUEST Trademark

Trademark Overview

On Friday, September 18, 2015, a trademark application was filed for FOQUEST with the United States Patent and Trademark Office. The USPTO has given the FOQUEST trademark a serial number of 86761606. The federal status of this trademark filing is REGISTERED as of Tuesday, June 5, 2018. This trademark is owned by Purdue Pharma. The FOQUEST trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of diseases and disorders of the central nervous system; pharmaceutical preparations for the treatment of diseases and disorders of the central nervous system, namely, attention deficit disorder, attention deficit hyperactivity disorder, hyperactivity, cognitive impairment disorders
foquest

General Information

Serial Number86761606
Word MarkFOQUEST
Filing DateFriday, September 18, 2015
Status700 - REGISTERED
Status DateTuesday, June 5, 2018
Registration Number5483378
Registration DateTuesday, June 5, 2018
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 20, 2018

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of diseases and disorders of the central nervous system; pharmaceutical preparations for the treatment of diseases and disorders of the central nervous system, namely, attention deficit disorder, attention deficit hyperactivity disorder, hyperactivity, cognitive impairment disorders

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, September 22, 2015
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NamePurdue Pharma
Party Type30 - Original Registrant
Legal Entity Type13 - Limited Partnership
AddressToronto, Ontario M2H3S7
CA
Party NamePurdue Pharma
Party Type20 - Owner at Publication
Legal Entity Type13 - Limited Partnership
AddressPickering, Ontario L1W3W8
CA
Party NamePurdue Pharma
Party Type10 - Original Applicant
Legal Entity Type13 - Limited Partnership
AddressPickering, Ontario L1W3W8
CA

Trademark Events

Event DateEvent Description
Monday, June 5, 2023COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Thursday, October 7, 2021APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, October 7, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, October 7, 2021TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Thursday, October 7, 2021TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Thursday, October 7, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, October 7, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, October 7, 2021TEAS CHANGE OF OWNER ADDRESS RECEIVED
Monday, November 4, 2019REVIEW OF CORRESPONDENCE COMPLETE - POWER OF ATTORNEY ENTERED
Thursday, September 26, 2019TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Tuesday, July 3, 2018REVIEW OF CORRESPONDENCE COMPLETE - POWER OF ATTORNEY ENTERED
Friday, June 29, 2018TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Tuesday, June 5, 2018REGISTERED-PRINCIPAL REGISTER
Tuesday, March 20, 2018OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 20, 2018PUBLISHED FOR OPPOSITION
Wednesday, February 28, 2018NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, February 12, 2018APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, February 8, 2018TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, February 8, 2018CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, February 5, 2018TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Thursday, September 7, 2017NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Thursday, September 7, 2017INQUIRY TO SUSPENSION E-MAILED
Thursday, September 7, 2017SUSPENSION INQUIRY WRITTEN
Tuesday, August 22, 2017SUSPENSION CHECKED ¿ TO ATTORNEY FOR ACTION
Wednesday, February 15, 2017NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Wednesday, February 15, 2017LETTER OF SUSPENSION E-MAILED
Wednesday, February 15, 2017SUSPENSION LETTER WRITTEN
Wednesday, January 25, 2017TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, January 25, 2017CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, January 23, 2017TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Friday, July 29, 2016NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Friday, July 29, 2016INQUIRY TO SUSPENSION E-MAILED
Friday, July 29, 2016SUSPENSION INQUIRY WRITTEN
Thursday, July 21, 2016ASSIGNED TO LIE
Friday, January 8, 2016NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Friday, January 8, 2016LETTER OF SUSPENSION E-MAILED
Friday, January 8, 2016SUSPENSION LETTER WRITTEN
Tuesday, January 5, 2016ASSIGNED TO EXAMINER
Tuesday, September 22, 2015NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, September 22, 2015NEW APPLICATION ENTERED

Related Keywords

foquest disorders attention deficit disorder hyperactivity pharmaceutical system treatment preparations nervous